K. Yanagisawa

Impaired Proliferative Response of Vα24 NKT Cells from Cancer Patients Against α-Galactosylceramide1

M. Nozue, T. Todoroki, K. Seino, 2002, The Journal of Immunology.

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance

Y. Iwakura, M. Taniguchi, T. Nakayama, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Cancellation of NKT cell immunosuppression targeting myeloid suppressor cells

K. Seino, H. Wada, K. Yanagisawa, 2009 .

Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.

Xiaofeng Jiang, M. Taniguchi, M. Exley, 2006, Cancer research.

Ex vivo Analysis of Resident Hepatic Pro-inflammatory CD 1 d-reactive T cells & Hepatocyte Surface CD 1 d Expression in Hepatitis C

D. Schuppan, M. Exley, Nádia, 2014 .

Ex vivo analysis of resident hepatic pro‐inflammatory CD1d‐reactive T cells and hepatocyte surface CD1d expression in hepatitis C

D. Schuppan, M. Exley, H. Rosen, 2013, Journal of viral hepatitis.

Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide.

M. Nozue, T. Todoroki, K. Seino, 2002, Journal of immunology.

The effect of alpha-galactosylceramide upon allogenic rejection.

Y. Takada, K. Seino, K. Fukao, 2001, Transplantation proceedings.